Dmitry V. Demchuk

Dr. Dmitry V. Demchuk

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
DDDmitry V. Demchuk
Dmitry V. Demchuk
ASAlexander V. Samet
Alexander V. Samet
NCNatalia B. Chernysheva
Natalia B. Chernysheva
VUVladimir I. Ushkarov
Vladimir I. Ushkarov
GSGalina A. Stashina
Galina A. Stashina
VSVictor V. Semenov
Victor V. Semenov

1 January 1997 in Russian Chemical Bulletin
Verified
Journal Article
Closed access
PDF file
DDDmitry V. Demchuk
Dmitry V. Demchuk
GNG. I. Nikishin
G. I. Nikishin

23 July 2023 in Molbank
Verified
Journal Article
Open access
PDF file
OAOlga Igorevna Adaeva
Olga Igorevna Adaeva
DDDmitry V. Demchuk
Dmitry V. Demchuk
VSVictor V. Semenov
Victor V. Semenov
This article presents a novel approach for synthesizing a new 5,8-dimethoxy derivative of esculetin via the selective cleavage of the methylene bridge in sabandin—naturally occurring and easily synthetically accessible methoxylated coumarin. A high selectivity is achieved by using acetoxylation of methylenedioxy group with lead tetraacetate. Natural coumarin sabandin as a starting compound was prepared in a few simple steps from 5-allyl-4,7-dimethoxybenzo[d][1,3]dioxole (apiol), which is readily available from parsley and dill seed extracts. The developed method enables an efficient and straightforward synthesis of a new derivative of esculetin with potential medicinal and therapeutic applications.

1 January 2006 in Russian Chemical Bulletin
Verified
Journal Article
Closed access
PDF file
AMA. V. Miroshnichenko
A. V. Miroshnichenko
DDDmitry V. Demchuk
Dmitry V. Demchuk
GNG. I. Nikishin
G. I. Nikishin

27 November 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
OKOlga Kulikova
Olga Kulikova
OAOlga Igorevna Adaeva
Olga Igorevna Adaeva
YTYulia Timoshina
Yulia Timoshina
DADenis Abaimov
Denis Abaimov
OMOlga Muzychuk
Olga Muzychuk
TFTatiana Fedorova
Tatiana Fedorova
Parkinson’s disease (PD) therapy is challenged by the multifactorial nature of neurodegeneration, necessitating an approach combining dopamine replenishment and combating oxidative stress. This study characterizes the neuroprotective potential of MQPD, a novel hybrid molecule containing dopamine with a quinone fragment structurally analogous to coenzyme Q. We evaluated MQPD’s antioxidant capacity in vitro using DPPH radical scavenging and lipid peroxidation assays, its neuroprotective efficacy against mitochondrial toxins (rotenone, paraquat) in neuronal cultures, and its ability to modulate striatal dopamine levels in mice. MQPD demonstrated significant antioxidant activity, reduced reactive oxygen species, and was more effective than dopamine or L-DOPA in mitigating toxin-induced cell death. While MQPD itself showed low brain bioavailability, its administration resulted in a sustained increase in striatal dopamine levels for up to four days. The results indicate that MQPD is a potent neuroprotective agent whose effects are likely mediated by direct antioxidant activity and a long-acting mechanism that stabilizes tissue dopamine levels, offering a promising alternative to current therapies for PD.

1 October 1998 in Russian Chemical Bulletin
Verified
Journal Article
Closed access
PDF file
DDDmitry V. Demchuk
Dmitry V. Demchuk
GNG. I. Nikishin
G. I. Nikishin